Patents by Inventor Barbara Seymour

Barbara Seymour has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180273889
    Abstract: Described is a device comprising an anchor, a tray including a well adapted to receive the anchor, and a cover adapted to engage the tray and cover the well. The device may be used to form a membrane-cell matrix having a substantially uniform distribution of the cells on the membrane in at least two dimensions.
    Type: Application
    Filed: May 31, 2018
    Publication date: September 27, 2018
    Inventors: Yongzhong Wang, Christopher KELLY, Stephen RAPKO, Frank QUINNO, Barbara SEYMOUR
  • Patent number: 10011811
    Abstract: Described is a device comprising an anchor, a tray including a well adapted to receive the anchor, and a cover adapted to engage the tray and cover the well. The device may be used to form a membrane-cell matrix having a substantially uniform distribution of the cells on the membrane in at least two dimensions.
    Type: Grant
    Filed: November 25, 2013
    Date of Patent: July 3, 2018
    Assignee: Vericel Corporation
    Inventors: Yongzhong Wang, Christopher Kelly, Stephen Rapko, Frank Quinno, Barbara Seymour
  • Publication number: 20150147809
    Abstract: Described is a device comprising an anchor, a tray including a well adapted to receive the anchor, and a cover adapted to engage the tray and cover the well. The device may be used to form a membrane-cell matrix having a substantially uniform distribution of the cells on the membrane in at least two dimensions.
    Type: Application
    Filed: November 25, 2013
    Publication date: May 28, 2015
    Inventors: Yongzhong WANG, Christopher KELLY, Stephen RAPKO, Frank QUINNO, Barbara SEYMOUR
  • Publication number: 20130273010
    Abstract: The present invention provides defined serum-free cell culture media useful in culturing fibroblasts, especially articular chondrocytes, that avoid problems inherent in the use of serum-containing media. The defined media comprise platelet-derived growth factor (PDGF), chemically defined lipids, oncostatin M (OSM), interleukin-6 (IL-6), leukemia inhibitory factor (LIF), or combinations of these compounds. In another aspect, the present invention also provides tissue culture methods that comprise incubating chondrocytes in the defined serum-free media. The methods enhance attachment and proliferative expansion of chondrocytes seeded at low density while maintaining their redifferentiation potential.
    Type: Application
    Filed: April 16, 2013
    Publication date: October 17, 2013
    Applicant: GENZYME CORPORATION
    Inventors: Stephen DUGUAY, Barbara SEYMOUR
  • Publication number: 20120213745
    Abstract: The present invention provides defined serum-free cell culture media useful in culturing fibroblasts, especially articular chondrocytes, that avoid problems inherent in the use of serum-containing media. The defined media comprise platelet-derived growth factor (PDGF), chemically defined lipids, oncostatin M (OSM), interleukin-6 (IL-6), leukemia inhibitory factor (LIF), or combinations of these compounds. In another aspect, the present invention also provides tissue culture methods that comprise incubating chondrocytes in the defined serum-free media. The methods enhance attachment and proliferative expansion of chondrocytes seeded at low density while maintaining their redifferentiation potential.
    Type: Application
    Filed: February 21, 2012
    Publication date: August 23, 2012
    Inventors: Stephen DUGUAY, Barbara SEYMOUR
  • Patent number: 8074465
    Abstract: The present invention provides a temperature sensitive transport container (20) for packaging and shipping cell-based products such as cultured cells intended for transplantation. In particular, the present disclosure provides a thermally insulated transport container system (10) for storing and transporting cells for transplantation which is capable of maintaining the cells at a desirable temperature range for a sufficient period of time to ensure adequate cell viability and therapeutic properties.
    Type: Grant
    Filed: September 11, 2006
    Date of Patent: December 13, 2011
    Assignee: Genzyme Corporation
    Inventors: Adam Heroux, Barbara Seymour
  • Publication number: 20080276643
    Abstract: The present invention provides a temperature sensitive transport container (20) for packaging and shipping cell-based products such as cultured cells intended for transplantation. In particular, the present disclosure provides a thermally insulated transport container system (10) for storing and transporting cells for transplantation which is capable of maintaining the cells at a desirable temperature range for a sufficient period of time to ensure adequate cell viability and therapeutic properties.
    Type: Application
    Filed: September 11, 2006
    Publication date: November 13, 2008
    Inventors: Adam Heroux, Barbara Seymour
  • Publication number: 20070292949
    Abstract: The present invention provides defined serum-free cell culture media useful in culturing fibroblasts, especially articular chondrocytes, that avoid problems inherent in the use of serum-containing media. The defined media comprise platelet-derived growth factor (PDGF), chemically defined lipids, oncostatin M (OSM), interleukin-6 (IL-6), leukemia inhibitory factor (LIF), or combinations of these compounds. In another aspect, the present invention also provides tissue culture methods that comprise incubating chondrocytes in the defined serum-free media. The methods enhance attachment and proliferative expansion of chondrocytes seeded at low density while maintaining their redifferentiation potential.
    Type: Application
    Filed: June 15, 2007
    Publication date: December 20, 2007
    Applicant: Genzyme Corporation
    Inventors: Stephen Duguay, Barbara Seymour